AU Stock MarketDetailed Quotes

NUZ Neurizon Therapeutics Ltd

Watchlist

0.175
0.0000.00%

20min DelayNot Open Nov 28 16:00 AET

86.05MMarket Cap-8333P/E (Static)

Neurizon Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2024

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Total revenue

-16.48%2.82M

57.98%3.38M

-33.03%2.14M

3.2M

Operating revenue

----

-16.48%2.82M

57.98%3.38M

-33.03%2.14M

--3.2M

Cost of revenue

150.53%787.54K

39.51%314.34K

-8.47%225.32K

246.16K

Gross profit

-33.60%2.04M

60.15%3.07M

-35.08%1.92M

2.95M

Operating expense

16.07%6.66M

-1.36%5.74M

23.58%5.82M

-8.09%4.71M

5.12M

Selling and administrative expenses

-34.66%2.81M

-9.32%4.3M

23.11%4.74M

-9.16%3.85M

--4.24M

-General and administrative expense

-34.66%2.81M

-9.32%4.3M

23.11%4.74M

-9.16%3.85M

--4.24M

Research and development costs

272.85%3.85M

35.99%1.03M

36.91%758.66K

-8.46%554.14K

--605.35K

Depreciation amortization depletion

-99.50%1.64K

3.69%326.55K

4.99%314.93K

9.22%299.97K

--274.64K

-Depreciation and amortization

-99.50%1.64K

3.69%326.55K

4.99%314.93K

9.22%299.97K

--274.64K

Provision for doubtful accounts

----

--77.98K

----

Operating profit

-79.93%-6.66M

-34.61%-3.7M

1.51%-2.75M

-28.57%-2.79M

-2.17M

Net non-operating interest income (expenses)

3,023.30%24.47K

99.05%-837

-36.89%-87.98K

44.21%-64.27K

-115.21K

Non-operating interest income

-69.80%24.47K

15,016.60%81.03K

-96.36%536

347.36%14.72K

--3.29K

Non-operating interest expense

----

-7.51%81.86K

12.06%88.51K

-33.34%78.99K

--118.5K

Other net income (expenses)

9.73%-2.27M

-322.35%-2.51M

-25.56%1.13M

64.09%1.52M

924.23K

Special income (charges)

11.35%-3.11M

---3.51M

----

-Less:Impairment of capital assets

-11.35%3.11M

--3.51M

----

Other non-operating income (expenses)

-15.44%841.71K

-11.83%995.37K

-25.56%1.13M

64.09%1.52M

--924.23K

Income before tax

-43.28%-8.9M

-263.63%-6.21M

-27.73%-1.71M

1.81%-1.34M

-1.36M

Income tax

Earnings from equity interest net of tax

Net income

-23.53%-7.67M

-263.63%-6.21M

-27.73%-1.71M

1.81%-1.34M

-1.36M

Net income continuous operations

-43.28%-8.9M

-263.63%-6.21M

-27.73%-1.71M

1.81%-1.34M

---1.36M

Net income discontinuous operations

--1.23M

----

Noncontrolling interests

Net income attributable to the company

-23.53%-7.67M

-263.63%-6.21M

-27.73%-1.71M

1.81%-1.34M

-1.36M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

-23.53%-7.67M

-263.63%-6.21M

-27.73%-1.71M

1.81%-1.34M

-1.36M

Diluted earnings per share

-7.25%-0.0207

-257.41%-0.0193

-28.57%-0.0054

8.70%-0.0042

-0.0046

Basic earnings per share

-7.25%-0.0207

-257.41%-0.0193

-28.57%-0.0054

8.70%-0.0042

-0.0046

Dividend per share

Accounting Standards

US-GAAP

	(FY)Jun 30, 2024	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Total revenue		-16.48%2.82M	57.98%3.38M	-33.03%2.14M	3.2M
Operating revenue	----	-16.48%2.82M	57.98%3.38M	-33.03%2.14M	--3.2M
Cost of revenue		150.53%787.54K	39.51%314.34K	-8.47%225.32K	246.16K
Gross profit		-33.60%2.04M	60.15%3.07M	-35.08%1.92M	2.95M
Operating expense	16.07%6.66M	-1.36%5.74M	23.58%5.82M	-8.09%4.71M	5.12M
Selling and administrative expenses	-34.66%2.81M	-9.32%4.3M	23.11%4.74M	-9.16%3.85M	--4.24M
-General and administrative expense	-34.66%2.81M	-9.32%4.3M	23.11%4.74M	-9.16%3.85M	--4.24M
Research and development costs	272.85%3.85M	35.99%1.03M	36.91%758.66K	-8.46%554.14K	--605.35K
Depreciation amortization depletion	-99.50%1.64K	3.69%326.55K	4.99%314.93K	9.22%299.97K	--274.64K
-Depreciation and amortization	-99.50%1.64K	3.69%326.55K	4.99%314.93K	9.22%299.97K	--274.64K
Provision for doubtful accounts	----	--77.98K	----	----	----
Operating profit	-79.93%-6.66M	-34.61%-3.7M	1.51%-2.75M	-28.57%-2.79M	-2.17M
Net non-operating interest income (expenses)	3,023.30%24.47K	99.05%-837	-36.89%-87.98K	44.21%-64.27K	-115.21K
Non-operating interest income	-69.80%24.47K	15,016.60%81.03K	-96.36%536	347.36%14.72K	--3.29K
Non-operating interest expense	----	-7.51%81.86K	12.06%88.51K	-33.34%78.99K	--118.5K
Other net income (expenses)	9.73%-2.27M	-322.35%-2.51M	-25.56%1.13M	64.09%1.52M	924.23K
Special income (charges)	11.35%-3.11M	---3.51M	----	----	----
-Less:Impairment of capital assets	-11.35%3.11M	--3.51M	----	----	----
Other non-operating income (expenses)	-15.44%841.71K	-11.83%995.37K	-25.56%1.13M	64.09%1.52M	--924.23K
Income before tax	-43.28%-8.9M	-263.63%-6.21M	-27.73%-1.71M	1.81%-1.34M	-1.36M
Income tax	0	0	0	0	0
Earnings from equity interest net of tax
Net income	-23.53%-7.67M	-263.63%-6.21M	-27.73%-1.71M	1.81%-1.34M	-1.36M
Net income continuous operations	-43.28%-8.9M	-263.63%-6.21M	-27.73%-1.71M	1.81%-1.34M	---1.36M
Net income discontinuous operations	--1.23M	----	----	----	----
Noncontrolling interests
Net income attributable to the company	-23.53%-7.67M	-263.63%-6.21M	-27.73%-1.71M	1.81%-1.34M	-1.36M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders	-23.53%-7.67M	-263.63%-6.21M	-27.73%-1.71M	1.81%-1.34M	-1.36M
Diluted earnings per share	-7.25%-0.0207	-257.41%-0.0193	-28.57%-0.0054	8.70%-0.0042	-0.0046
Basic earnings per share	-7.25%-0.0207	-257.41%-0.0193	-28.57%-0.0054	8.70%-0.0042	-0.0046
Dividend per share
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data